Case Study: CIMPLRX powers explainable drug discovery with CDD Vault

Cimplrx boosts hit rate to 30% with CDD Vault

Cimplrx, a drug discovery company based in South Korea, faced the challenge of managing complex and diverse experimental data to power its explainable AI platform. To bridge the gap between medicinal chemistry and computation, they needed a centralized system to structure their chemical and biological data for effective analysis and AI reasoning. They adopted CDD Vault from vendor CDD Vault to serve as their foundational data repository.

The solution implemented by CDD Vault provided a structured data pool accessible via its API, enabling Cimplrx to seamlessly integrate compound registration and assay results into its AI workflows. This supported advanced analyses and the company's innovative workspace-augmented generation (WAG) approach. The measurable impact was a dramatically improved hit rate in one collaboration; where a partner's traditional screening had a 0.1% hit rate, Cimplrx's data-driven approach achieved a 30% hit rate by testing only 36 compounds. CDD Vault was a key enabler in making scientific decision-making more insightful and effective.

Cimplrx